1. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials;Modjarrad;Lancet,2017
2. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials;Gaudinski;Lancet,2017
3. Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil;Cordeiro;Lancet,2016
4. Initial description of the presumed congenital Zika syndrome;Miranda-Filho Dde;Am J Public Health,2016
5. Antigenic activity of poliomyelitis vaccines undergoing field test;Salk;Am J Public Health Nations Health,1955